|What is the key to accessible clinical|
trials for patients?
Not only do clinical trials for cancer treatments advance the science and lead towards cures but they also often provide better overall care for the patients. Patients who participate in trials receive follow up, more treatment guidelines and are better able to manage treatment for their disease. They also have frequent interaction with healthcare professionals who are closely monitoring their disease as well as hope that traditional treatments might not provide. By finding new and innovative ways to allow patients to participate in clinical trials, this allows patients who may not live near a trial site to access in a potentially life saving treatment.
In your opinion, what is one of the major setbacks to creating a more accessible clinical trials for patients with difficult to treat cancers?
Connecting the Innovation Dots: Solutions to the Disconnection Between the Pace of Technology and Traditional Approaches to Clinical Trials presented by by Donald Jones, Chief Digital Officer, Scripps Translational Science Institute will look at how trials can be rethought and give the opportunity to more cancer patients more access to participate in clinical trials. For more information on this session and the rest of the Partnerships in Clinical Trials program, download the preliminary agenda. If you'd like to join us April 22-24, 2015 in Boston, as a reader of this blog when you register to join us and mention code XP2000BL, you can save $100 off the current rate!